Quantcast

Latest Organofluorides Stories

2014-10-18 23:01:41

The Firm is representing numerous Risperdal lawsuit plaintiffs in claims that allege the atypical antipsychotic medication caused gynecomastia, or male breast growth. New York, New York (PRWEB) October 18, 2014 Risperdal lawsuits (http://www.risperdallawsuitcenter.com/) continue to mount in a mass tort litigation now underway in Pennsylvania’s Philadelphia Court of Common Pleas, Bernstein Liebhard LLP reports. According to court documents, 888 product liability claims have been filed in...

2014-10-17 12:24:41

DUBLIN, October 17, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/f9njsq/micro_market) has announced the addition of the "Micro Market Monitor : North America Fluoropolymers Coating Additives Market" [http://www.researchandmarkets.com/research/f9njsq/micro_market ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Fluoropolymers Coating Additives-North American market was...

2014-10-16 12:28:14

Launch of Novel Immune Checkpoint Inhibitors Will Fuel Market Growth and Will Dramatically Enhance RCC Treatment Algorithm, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct. 16, 2014 /PRNewswire/ -- Decision Resources Group finds that the market for renal cell carcinoma (RCC) therapies will grow to approximately $2.5 billion by 2023, despite the aggressive generic erosion of Pfizer's Sutent, GlaxoSmithKline's Votrient, Pfizer's Inlyta, Bayer HealthCare/Onyx...

2014-10-15 23:01:37

New research report “Global Cancer Kinase Inhibitors Market & Pipeline Insight” elaborated by Kuick Research is now available at MarketPublishers.com. According to the study, the global kinase inhibitors market is poised to gain momentum through 2018. London, UK (PRWEB) October 15, 2014 The field of cancer is developing driven primarily by the ageing world population, soaring rates of smoking, and the growth in obesity across all geographies. This opens up a slew of nice...

2014-10-15 12:31:56

NEW YORK, Oct. 15, 2014 /PRNewswire/ -- As Risperdal lawsuits (http://www.risperdallawsuitcenter.com/) continue to mount in U.S. courts, a hearing recently held in Vermont is raising serious questions about the adherence to pediatric dosing guidelines by doctors who prescribe antipsychotic drugs like Risperdal to children, Bernstein Liebhard LLP reports. According to Dr. David C. Rettew, Director of the Pediatric Psychiatry Clinic at University of Vermont's College of Medicine, a...

2014-10-15 08:29:30

BUFFALO, N.Y., Oct. 15, 2014 /PRNewswire/ -- Hanmi Pharmaceuticals and Collaborative Partner Kinex Pharmaceuticals announce today preliminary results from a Phase I Clinical Study of Oratecan - an oral form of the approved intravenously administered cancer drug irinotecan, with HM30181, a potent and selective, P-glycoprotein inhibitor of the gastro-intestinal tract. Irinotecan is a type 1 DNA topoisomerase inhibitor, marketed under the trade name Camptosar. It is approved for the...

2014-10-14 16:28:47

WASHINGTON, Oct. 14, 2014 /PRNewswire/ -- Thirty-one former customers have filed suit in New Jersey State Court against Mario Badescu, Inc., a skincare company based out of Edison, New Jersey, and Mario Badescu Skin Care, Inc., a skincare salon in New York. The plaintiffs allege that they were injured by potent and undisclosed steroids in two of Mario Badescu's face creams, Control Cream and Healing Cream, which were marketed as products that contained only "botanical" active...

2014-10-14 08:33:40

MIAMI and NEW YORK, Oct. 14, 2014 /PRNewswire/ -- Noven Pharmaceuticals, Inc., today announced the publication of data on the effects of low-dose mesylate salt of paroxetine (LDMP), marketed as Brisdelle(® )(paroxetine) capsules, 7.5 mg, in the October 2014 issue of Menopause, the peer-reviewed, scientific journal of The North American Menopause Society (NAMS). The article, "Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated...

2014-10-14 08:33:29

DUBLIN, Oct. 14, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Cancer Kinase Inhibitors Market & Pipeline Insight" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 The recent years have witnessed the emergence of kinase inhibitors, which have the potential to offer less toxic and more efficient therapeutic alternatives for patients. Over the past two decades, the researchers have increased their learning about the...

2014-10-11 23:03:48

Risperdal Lawsuit Claims Continue With Meeting Scheduled In October For Gynecomastia Lawsuits Pending Litigation Columbus, OH (PRWEB) October 11, 2014 As Risperdal lawsuit claims continue in the Philadelphia Court of Common Pleas, another monthly meeting has been scheduled for parties to discuss the litigation surrounding antipsychotic drugs and the development of male breasts or gynecomastia. According to court records there are nearly 80 Risperdal lawsuit claims pending in the...


Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related